9781617372575 - Cell Cycle Inhibitors in Cancer Therapy: Current Strategies (cancer Drug Discovery and Development) (10 results)
Language: English
Published by Humana, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
Seller: California Books, Miami, FL, U.S.A.California Books
Contact seller4-star sellerCondition: New
£ 152.38
Free ShippingShips within U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Humana, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 137.84
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Humana Press Inc., 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
- First Edition
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrelandKennys Bookshop and Art Galleries Ltd.
Contact seller5-star sellerCondition: New
£ 173.23
£ 8.13 shippingShips from Ireland to U.S.A.Quantity: 15 available
Condition: New. Editor(s): Giordano, Antonio; Soprano, Kenneth J. Series: Cancer Drug Discovery and Development. Num Pages: 326 pages, 22 black & white illustrations, biography. BIC Classification: MQP. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 19. Weight in Grams: 499. . 2010. 1st ed. Softcover of orig. ed…. 2003. Paperback. . . . .
Language: English
Published by Humana, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 123.46
£ 59.89 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Cell Cycle Inhibitors in Cancer Therapy | Current Strategies | Antonio Giordano (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | x | Englisch | 2010 | Humana | EAN 9781617372575 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3…, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Language: English
Published by Humana Press Inc., 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
Seller: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contact seller5-star sellerCondition: New
£ 208.65
£ 7.69 shippingShips within U.S.A.Quantity: 15 available
Condition: New. Editor(s): Giordano, Antonio; Soprano, Kenneth J. Series: Cancer Drug Discovery and Development. Num Pages: 326 pages, 22 black & white illustrations, biography. BIC Classification: MQP. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 19. Weight in Grams: 499. . 2010. 1st ed. Softcover of orig. ed…. 2003. Paperback. . . . . Books ship from the US and Ireland.
Language: English
Published by Humana, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
- Print on Demand
Seller: Brook Bookstore On Demand, Napoli, NA, ItalyBrook Bookstore On Demand
Contact seller5-star sellerCondition: New
£ 111.27
£ 4.71 shippingShips from Italy to U.S.A.Quantity: Over 20 available
Condition: new. Questo è un articolo print on demand.
Language: English
Published by Humana Press Nov 2010, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 141.43
£ 19.68 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The molecular approach to disease continues to yield a tremendous amount of new information about those aspects of cellular replication that we use to understand, prevent, diagnose, and cure cancer. In Cell Cycle Inhibitors in Cance…r Therapy: Current Strategies, recognized clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell-cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor-suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. Up-to-date and richly instructive, Cell Cycle Inhibitors in Cancer Therapy: Current Strategies brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease. 340 pp. Englisch.
Language: English
Published by Humana Press, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
- Print on Demand
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 119.99
£ 41.92 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understand…ing neoplastic diseases. Topics range fr.
Language: English
Published by Humana Press, Humana Press Nov 2010, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 141.43
£ 51.34 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic dise…ases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. The book brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 340 pp. Englisch.
Language: English
Published by Humana Press, Humana Press, 2010
Series: Book 15 of 96 - Cancer Drug Discovery and Development
- Softcover
- Print on Demand
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 148.70
£ 53.45 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The molecular approach to disease continues to yield a tremendous amount of new information about those aspects of cellular replication that we use to understand, prevent, diagnose, and cure cancer. In Cell Cycle Inhibitors in Cancer The…rapy: Current Strategies, recognized clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell-cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor-suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. Up-to-date and richly instructive, Cell Cycle Inhibitors in Cancer Therapy: Current Strategies brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease.
